Position in ANIP
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,856,323
+$2,131,695 QoQ
Shares Held
34,505
+266.2% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#92
of 305 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $54,645,005 across 16 Drug Manufacturers - Specialty & Generic names. ANIP ranks #8 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
147,055 | $10,567,372 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
14,271 | $7,732,455 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
190,145 | $6,592,327 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
136,725 | $5,609,826 | |
| 5 | VTRS |
Viatris Inc
|
331,130 | $5,258,344 | |
| 6 | PRGO |
PERRIGO Co plc
|
346,586 | $3,601,028 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
411,346 | $3,257,860 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
This page
|
34,505 | $2,856,323 |
All Filings in ANIP
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,856,323 | 34,505 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $724,628 | 9,423 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,584,349 | 45,406 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $704,404 | 7,690 | Shares | Sole | 2025-10-31 | |
| 2024-09-30 | $404,554 | 6,781 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||